Education
About Us
Working with TipRanks
Follow Us
Option Care Health Inc (OPCH)
NASDAQ:OPCH
OPCH Stock Chart & Stats
$33.85
-$0.14(-0.58%)
At close: 4:00 PM EST
$33.85
-$0.14(-0.58%)
Day’s Range― - ―
52-Week Range$24.24 - $36.80
Previous CloseN/A
Volume256.90K
Average Volume (3M)1.52M
Market Cap
$5.37B
Enterprise Value$6.46B
Total Cash (Recent Filing)$309.82M
Total Debt (Recent Filing)$1.28B
Price to Earnings (P/E)26.9
Beta0.32
Next Earnings
Feb 24, 2026EPS Estimate
0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.45
Shares Outstanding158,732,710
10 Day Avg. Volume1,431,858
30 Day Avg. Volume1,519,147
Financial Highlights & Ratios
PEG Ratio-1.08
Price to Book (P/B)2.83
Price to Sales (P/S)0.80
P/FCF Ratio13.83
Enterprise Value/Market Cap1.20
Enterprise Value/Revenue1.17
Enterprise Value/Gross Profit6.02
Enterprise Value/Ebitda14.02
Forecast
1Y Price Target
$38.75Price Target Upside14.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Capital Return PolicyBoard-approved expansion of the share repurchase authorization signals management confidence in cash flow and supports ongoing buybacks and small strategic acquisitions.
Market Positioning And Long-term DemandScaled home- and alternate-site infusion network and strong payer relationships position the company to capture demand from aging demographics and the shift to lower-cost care, supporting attractive long-term revenue and EBITDA growth.
Product Concentration Risk ReductionReduced reliance on a single therapy materially lowers concentration risk, positioning the company to resume stronger revenue growth and expand profit margins.
Bears Say
Pricing And Biosimilar CompetitionPricing changes and the emergence of biosimilars, together with policy-linked reimbursement shifts, are expected to create headwinds to revenue and gross profit and pressure margins.
Product-specific Revenue HeadwindExpected loss of sales from a key competing therapy is likely to reduce revenue growth and delay the return to a long-term double-digit EBITDA growth trajectory, with the impact larger than prior estimates.
Valuation And Analyst RepricingAnalyst-driven price target reductions based on revised cash flow assumptions imply a lower market valuation tied to updated 2026 EBITDA expectations, which could limit upside for the shares.
Option Care Health News
OPCH FAQ
What was Option Care Health Inc’s price range in the past 12 months?
Option Care Health Inc lowest stock price was $24.23 and its highest was $36.80 in the past 12 months.
What is Option Care Health Inc’s market cap?
Option Care Health Inc’s market cap is $5.37B.
When is Option Care Health Inc’s upcoming earnings report date?
Option Care Health Inc’s upcoming earnings report date is Feb 24, 2026 which is in 19 days.
How were Option Care Health Inc’s earnings last quarter?
Option Care Health Inc released its earnings results on Oct 30, 2025. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02.
Is Option Care Health Inc overvalued?
According to Wall Street analysts Option Care Health Inc’s price is currently Undervalued.
Does Option Care Health Inc pay dividends?
Option Care Health Inc does not currently pay dividends.
What is Option Care Health Inc’s EPS estimate?
Option Care Health Inc’s EPS estimate is 0.47.
How many shares outstanding does Option Care Health Inc have?
Option Care Health Inc has 158,732,710 shares outstanding.
What happened to Option Care Health Inc’s price movement after its last earnings report?
Option Care Health Inc reported an EPS of $0.45 in its last earnings report, beating expectations of $0.43. Following the earnings report the stock price went down -8.615%.
Which hedge fund is a major shareholder of Option Care Health Inc?
Currently, no hedge funds are holding shares in OPCH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Option Care Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.75 (14.48% Upside)
$38.75 (14.48% Upside)
Blogger Sentiment
Bullish
OPCH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 486.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.2%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.54%
12-Months-Change
Fundamentals
Return on Equity
15.02%
Trailing 12-Months
Asset Growth
1.52%
Trailing 12-Months
Company Description
Option Care Health Inc
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
OPCH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Option Care Health's earnings call showcased strong revenue growth and raised guidance, driven by expansion in infusion services and effective capital management. However, the impact of Stelara biosimilars and pressure on gross margins posed challenges.View all OPCH earnings summariesOPCH Stock 12 Month Forecast
Average Price Target
$38.75
▲(14.48% Upside)
Technical Analysis
Addus Homecare
―
Chemed
―
National Healthcare
―
Surgery Partners
―
Aveanna Healthcare Holdings
―
Ownership Overview
1.41% Insiders
38.94% Mutual Funds
2.54% Other Institutional Investors
30.94% Public Companies and
Individual Investors